| 发明名称 |
Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease |
| 摘要 |
The present invention relates to the combination of one or more CB1 antagonist azetidine derivatives and of one or more products which activate dopaminergic neurotransmission in the brain, to the pharmaceutical compositions comprising them and to their use in the treatment of Parkinson's disease.
|
| 申请公布号 |
US7217705(B2) |
申请公布日期 |
2007.05.15 |
| 申请号 |
US20040786810 |
申请日期 |
2004.02.25 |
| 申请人 |
AVENTIS PHARMA S.A. |
发明人 |
BENAVIDES JESUS;BOCCIO DANIEL;HENIN YVETTE;PIOT-GROSJEAN ODILE |
| 分类号 |
A01N43/00;A61K45/00;A01N37/10;A01N43/40;A01N43/78;A61K31/198;A61K31/397;A61K31/4353;A61K31/4427;A61K45/06;A61P25/00;A61P25/16;A61P43/00 |
主分类号 |
A01N43/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
